1. Home
  2. RDW vs PBLS Comparison

RDW vs PBLS Comparison

Compare RDW & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwire Corporation

RDW

Redwire Corporation

HOLD

Current Price

$8.86

Market Cap

2.3B

Sector

Industrials

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$31.82

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RDW
PBLS
Founded
2020
N/A
Country
United States
United States
Employees
1410
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
3.6B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
RDW
PBLS
Price
$8.86
$31.82
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$13.71
N/A
AVG Volume (30 Days)
15.6M
463.8K
Earning Date
05-08-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.68
N/A
Revenue Next Year
$20.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.87
$25.56
52 Week High
$26.64
$33.65

Technical Indicators

Market Signals
Indicator
RDW
PBLS
Relative Strength Index (RSI) 36.99 57.89
Support Level $7.75 $26.83
Resistance Level $8.74 $33.65
Average True Range (ATR) 0.67 2.51
MACD 0.09 0.16
Stochastic Oscillator 22.50 69.57

Price Performance

Historical Comparison
RDW
PBLS

About RDW Redwire Corporation

Redwire Corp is an integrated space and defense technology company focused on technologies including aerospace infrastructure, autonomous systems and multi-domain operations, leveraging digital engineering and artificial intelligence automation. The Company develops and provides mission critical solutions based on space and defense technology platform offerings for government, commercial and civil customers through both short- and long-duration projects. These include technologies and production capability for next-generation spacecraft, large space infrastructure, microgravity capabilities, combat autonomous systems, optical sensors and radio frequency payloads that provide intelligence, surveillance, and reconnaissance capabilities for U.S. and allied nations across multiple domains.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: